Callosities, corns, and calluses.

D Singh; G Bentley; S G Trevino

doi:10.1136/bmj.312.7043.1403a

Home/Archive/PubMed

PubMed · 8646101

Callosities, corns, and calluses.

D Singh·G Bentley·S G Trevino

View original source ↗Export metadata ↓

Abstract

Inappropriate shoes, abnormal foot mechanics, and high levels of activity produce pressure and friction that lead to corns and calluses. Most lesions can be managed conservatively by proper footwear, orthoses, and, if necessary, regular paring. The lesions usually disappear when the causative mechanical forces are removed. Surgery is rarely indicated and should be specifically aimed at correcting the abnormal mechanical stresses.

Explore related subjects

Callosities Humans Orthotic Devices Physical Therapy Modalities Shoes Terminology as Topic Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

D Singh, G Bentley, S G Trevino. 1996-06-01. Callosities, corns, and calluses.. https://doi.org/10.1136/bmj.312.7043.1403a

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Letter: injectable silicone for painful interdigital neurovascular clavi and verrucae.

Explore the source record for details and available documents.

Callosities↗

PubMed2006

Xerosis and callus formation as a key to the diabetic foot syndrome: dermatologic view of the problem and its management.

The diabetic foot syndrome is a major complication of diabetes mellitus. The two most important pathophysiologic factors are peripheral arterial occlusion and peripheral neuropathy. The cutaneous lesion is a plantar ulcer, often accompanied by soft tissue and bone infections which can require amputation. Triggers include poorly fitting shoes, poor foot care, or overlooked foreign bodies, often coupled with a structural foot deformity. Increased plantar pressure, especially beneath the metatarsal heads, and the resultant callus play an important role. The patients often already have xerosis of the plantar skin with scales, fissures, erosions and impaired barrier function, complicating the situation. Prompt neurologic and vascular diagnostic studies, coupled with routine examination of the feet and primary prophylactic measures are most important. The most important therapeutic goals are optimal control of the diabetes mellitus, relieving pressure points and avoiding or reducing callus formation.

Callosities↗

PubMed2005

Injectable silicone and the foot: a 41-year clinical and histologic history.

BACKGROUND: Since 1964, the author has investigated injectable liquid silicone as a soft tissue substitute for the loss of plantar fat. This form of fatty tissue depletion over the sole is closely linked to a common painful weight-bearing foot disorder, metatarsalgia, and to painless diabetic foot ulcers. OBJECTIVES: To present the history of injectable silicone, corporate interest, individuals who helped pursue approval, its misuses, and events that have delayed its availability. MATERIALS AND METHODS: Dow Corning Corporation's 360 Medical Fluid of 350 centistoke was injected beneath corns and calluses in 1585 patients. Diabetic neuropathic foot ulcers were injected after healing in an effort to prevent their recurrence. Surgical and postmortem specimens were gathered for histologic analysis. RESULTS: There was no evidence of significant adverse response in long-term clinical follow-up. Silicone specimens studied by two departments of pathology found no inflammation, infection, allergy, or granulomas. CONCLUSIONS: Medical Fluid silicone appears to be safe, effective, and stable biomaterial for treating weight-bearing loss of plantar fat. Trademarked PodiSil (Richard-James Inc., Peabody, MA, USA), a 350-centistoke injectable silicone has been approved for marketing in Europe for the prevention of diabetic foot ulcers.

Callosities↗